Ravi Salgia to Immune System Diseases
This is a "connection" page, showing publications Ravi Salgia has written about Immune System Diseases.
Connection Strength
0.221
-
Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study. Lung Cancer. 2023 04; 178:166-171.
Score: 0.221
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.